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Background:  Subclinical left ventricular (LV) systolic dysfunction has been shown via tissue Doppler imaging (TDI) in patients with mitral stenosis. 
Previous studies have confirmed the diagnostic and prognostic role of N-teminal-Pro natriuretic peptide in LV dysfunction of different etiologies. Our 
objectives were to assess the effect of percutaneous balloon mitral valvuloplasty (PBMV) on LV systolic function and the plasma levels of NT-proBNP 
in patients with mitral stenosis.
Methods:  We investigated the changes in LV systolic function and in NT-pro-BNP plasma levels among 48 consecutive patients with mitral 
stenosis, 24 hours before and 6 months after PBMV& in 20 control healthy volunteers. TDI was used to evaluate systolic and diastolic mitral annular 
velocities, the myocardial performance index (MPI) and LV isovolumic myocardial acceleration.
Results:  Despite normal LV ejection fraction (58.4±4.1), LV systolic and diastolic mitral annular velocities, and isovolumic myocardial acceleration 
were significantly decreased in patients with mitral stenosis while MPI increased. All tissue Doppler parameters improved after PBMV. Mitral stenosis 
patients were found to have significantly higher levels of plasma NTproBNP compared to the control (857.5±658 pg/mL versus 165.0±80 pg/
mL,,P < 0.01]) which decreased significantly after PBMV. The percentage decrease in plasma NT- proBNP levels was correlated with the percentage 
increase in systolic mitral annular velocity , the percentage decrease in LV MPI and the percentage reduction in mean pulmonary artery pressure .By 
multivariate linear regression analysis this correlation persisted only for LV MPI & mean pulmonary artery pressure (`±SE = 0.41±0.14, P = 0.023 
and `±SE = 0.54±0.11, P = 0.004 respectively).
Conclusions: TDI and plasma NTproBNP levels can be reliably used for detection of subclinical LV systolic dysfunction in patients of mitral 
stenosis The percentage reduction in NTproBNP levels correlate well with that of myocardial performance index and mean pulmonary artery pressure 
and can be used as a noninvasive marker of procedural success after PBMV.
